- The poultry diagnostics market is projected to grow from $0.18 billion in 2026 to $0.25 billion by 2031
- PCR-based diagnostics are expected to dominate due to high sensitivity and early disease detection capabilities
- Consumables and reagents are forecast to see the fastest growth among product segments
- Broiler production is driving increased demand for routine diagnostic testing
- Asia-Pacific is expected to experience the fastest regional growth, while North America leads in market share
The global poultry diagnostics market is expected to grow steadily over the next several years, reaching $0.25 billion by 2031 from approximately $0.18 billion in 2026, according to a new report from MarketsandMarkets. The market is projected to expand at a compound annual growth rate of 7.1% during the forecast period.
Growth is being driven by increased demand for disease detection and surveillance, along with continued innovation in diagnostic technologies. Advances such as real-time PCR, multiplex assays, automated ELISA systems, and portable point-of-care platforms are improving the speed, sensitivity, and accuracy of pathogen identification in poultry populations.
Improved primer and probe design, enhanced reagents, and optimized assays are also contributing to more reliable detection of diseases such as avian influenza, Newcastle disease, and other rapidly evolving pathogens.
Product-level innovation remains a key driver of market expansion. New multiplex real-time PCR kits allow for simultaneous detection of multiple pathogens within a single test, offering higher sensitivity, broader strain coverage, and faster turnaround times. These systems are designed to integrate with existing laboratory platforms, supporting efficient, high-throughput testing.
The industry is also moving toward simplified workflows and ready-to-use reagents, improving usability and consistency across routine monitoring and emergency disease response programs.
PCR-based diagnostics accounted for the largest share of the market in 2025 and are expected to maintain their leading position. Their ability to detect infections at early stages with high accuracy makes them a critical tool for outbreak control and regulatory surveillance. Compatibility with multiplex testing and high-throughput workflows has further supported adoption across veterinary laboratories and government programs.
By poultry type, the broiler segment is expected to grow at the fastest rate during the forecast period. High stocking densities and short production cycles increase disease transmission risks, making routine diagnostic testing essential. Export requirements and strict biosecurity measures are also contributing to increased adoption of advanced diagnostic tools in broiler operations.
Regionally, North America held the largest share of the poultry diagnostics market in 2025, supported by a well-established commercial poultry industry, advanced laboratory infrastructure, and robust regulatory surveillance programs. High adoption of PCR and automated diagnostic technologies, along with government-led disease monitoring initiatives, continues to drive testing volumes in the region.
Meanwhile, the Asia-Pacific region is expected to register the fastest growth, driven by expanding poultry production, increasing disease awareness, and greater investment in diagnostic capabilities.
Key companies operating in the poultry diagnostics market include IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Bio-Rad Laboratories, and INDICAL BIOSCIENCE, among others.
Information sourced from the company’s press release.
